Selected article for: "death respiratory failure and respiratory failure"
Author: Wei-jie Guan; Wen-hua Liang; Yi Zhao; Heng-rui Liang; Zi-sheng Chen; Yi-min Li; Xiao-qing Liu; Ru-chong Chen; Chun-li Tang; Tao Wang; Chun-quan Ou; Li Li; Ping-yan Chen; Ling Sang; Wei Wang; Jian-fu Li; Cai-chen Li; Li-min Ou; Bo Cheng; Shan Xiong; Zheng-yi Ni; Yu Hu; Jie Xiang; Lei Liu; Hong Shan; Chun-liang Lei; Yi-xiang Peng; Li Wei; Yong Liu; Ya-hua Hu; Peng Peng; Jian-ming Wang; Ji-yang Liu; Zhong Chen; Gang Li; Zhi-jian Zheng; Shao-qin Qiu; Jie Luo; Chang-jiang Ye; Shao-yong Zhu; Lin-ling Cheng; Feng Ye; Shi-yue Li; Jin-ping Zheng; Nuo-fu Zhang; Nan-shan Zhong; Jian-xing He
Title: Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis
  • Document date: 2020_2_27
    • ID: 7s9ot4vq_9
    Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . https: //doi.org/10.1101 //doi.org/10. /2020 Respiratory Syndrome coronavirus (SARS-CoV) [15] and Middle East Respiratory Syndrome coronavirus (MERS-CoV) [16] [17] [18] [19] [20] [21] [22] [23] [24] , COVID-19 more readily predisposed to respiratory failure and death in susceptible patients [4] . Nonetheless, previous studies have been certain limitations in study desig.....
    Document: is the (which was not peer-reviewed) The copyright holder for this preprint . https: //doi.org/10.1101 //doi.org/10. /2020 Respiratory Syndrome coronavirus (SARS-CoV) [15] and Middle East Respiratory Syndrome coronavirus (MERS-CoV) [16] [17] [18] [19] [20] [21] [22] [23] [24] , COVID-19 more readily predisposed to respiratory failure and death in susceptible patients [4] . Nonetheless, previous studies have been certain limitations in study design including the relatively small sample sizes and single center observations. Studies that address these limitations is needed to explore for the factors underlying the adverse impact of COVID-19.

    Search related documents:
    Co phrase search for related documents
    • adverse impact and previous study: 1, 2, 3, 4, 5
    • adverse impact and respiratory failure: 1, 2, 3
    • adverse impact and Respiratory Syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • adverse impact and sample size: 1, 2
    • adverse impact and SARS CoV Respiratory Syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • adverse impact and single center: 1
    • adverse impact and study design: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • death respiratory failure and Middle East Respiratory Syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • death respiratory failure and previous study: 1
    • death respiratory failure and respiratory failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • death respiratory failure and Respiratory Syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • death respiratory failure and sample size: 1, 2, 3
    • death respiratory failure and SARS CoV Respiratory Syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • death respiratory failure and single center: 1, 2, 3, 4, 5
    • death respiratory failure and study design: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • limitation address and study design: 1
    • Middle East Respiratory Syndrome coronavirus and SARS CoV Respiratory Syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • Middle East Respiratory Syndrome coronavirus and single center: 1, 2, 3, 4, 5
    • Middle East Respiratory Syndrome coronavirus and study design: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25